Effect of Aidi Injection plus TACE on Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

Effect of Aidi Injection plus TACE on Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

We aim to conduct a meta-analysis of studies on the effect of Aidi injection combined with TACE in the treatment of hepatocellular carcinoma (HCC). China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Biomedical Literature Database (CBM), Chinese Science and Technology Periodica...

Full description

Bibliographic Details
Main Authors:	Yaoyao Dai, Sicheng Gao, Xing Liu, Qin Gao, Lan Zhang, Xingliang Fan, Junfeng Zhu
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2018/9196409

Similar Items

Mechanism of Aidi injection on hepatocellular carcinoma based on network pharmacology
by: Yuan-Yuan Ding, et al.
Published: (2020-04-01)

Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis.
by: Leida Zhang, et al.
Published: (2014-01-01)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
by: Wu-Kui Huang, et al.
Published: (2017-01-01)

A meta Analysis of Aidi Injection plus Taxotere and Cisplatin in the Treatment of Non-small Cell Lung Cancer
by: Quan WANG, et al.
Published: (2010-11-01)

Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
by: Yuan Lu, et al.
Published: (2021-09-01)

Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma
by: Zhaomin Song, et al.
Published: (2015-01-01)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
by: Li Chen, et al.
Published: (2021-03-01)

Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma
by: Ya-Qing Zhang MM, et al.
Published: (2017-10-01)

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression
by: Zou X, et al.
Published: (2021-05-01)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
by: Liyun Zheng, et al.
Published: (2021-01-01)

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
by: Jung Hee Kim, et al.
Published: (2017-03-01)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01)

Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials
by: Zheng Xiao, et al.
Published: (2018-01-01)

Efficacy and Safety of Aidi Injection Combined with Transcatheter Arterial Chemoembolization on Primary Hepatic Carcinoma: A Systematic Review and Meta-Analysis
by: Weihao Chen, et al.
Published: (2018-01-01)

Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma
by: Dong, C., et al.
Published: (2022)

Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma
by: Lingxiang Kong, et al.
Published: (2021-01-01)

TILA-TACE – an approach for effective local control of hepatocellular carcinoma
by: Ming Chao, et al.
Published: (2018-02-01)

Efficacy assessment of DC-CIK immunotherapy combined with TACE and RFA treatment of primary hepatocellular carcinoma
by: Xin-Hua Zuo, et al.
Published: (2016-02-01)

Aidi Injection as Adjuvant Drug Combined with Chemotherapy in Treatment of Breast Cancer: A Systematic Meta-Analysis
by: Chenhao Wu, et al.
Published: (2021-01-01)

Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
by: Wu J, et al.
Published: (2017-05-01)

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
by: Marmorale Cristina, et al.
Published: (2010-12-01)

Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
by: Wu Tao, et al.
Published: (2018-09-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma
by: Ying Wu, et al.
Published: (2020-07-01)

Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
by: Yashwant Patidar, et al.
Published: (2019-04-01)

Survival analysis of patients with medium and advanced hepatocellular carcinoma treated by TACE combined with Endostar
by: Xiu-Heng Qi, et al.
Published: (2020-10-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials
by: Cheng-Qiong Wang, et al.
Published: (2021-05-01)

Identifying a Six-Gene Signature Predicting Response to TACE in Hepatocellular Carcinoma by Bioinformatics Analysis
by: Xin Yao, et al.
Published: (2021-01-01)

Factors affecting tumor response to transarterial chemoembolization (TACE) therapy in patient with hepatocellular carcinoma (HCC)
by: Alia Amalia, et al.
Published: (2020-03-01)

Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE
by: Chung Hwan Jun, et al.
Published: (2013-03-01)

Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma.
by: Toru Ishikawa, et al.
Published: (2014-01-01)

Bile duct injury after TACE for primary hepatocellular carcinoma: a report of one case
by: ZHAO Kanglu
Published: (2014-11-01)

Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1
by: Yuan-dong Sun, et al.
Published: (2021-09-01)

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
by: Qu Xu-Dong, et al.
Published: (2012-06-01)

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Sitong Guo, et al.
Published: (2021-01-01)

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
by: Zeng Zhen, et al.
Published: (2012-12-01)

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
by: Bishay VL, et al.
Published: (2014-11-01)

Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE
by: Wang TC, et al.
Published: (2021-06-01)

Influence of Aidi injection combined with paclitaxel and platinum drugs on malignant molecule expression in malignant ascites of patients with advanced gastric cancer
by: Fan Yang, et al.
Published: (2017-09-01)